A handful of medical device companies have stepped up lately to address obesity, which wasn't even widely-recognized as a disease until a few years ago. Ethicon (Cincinnati) reported a $3.2 million investment in clinical research to better understand how earlier surgical intervention may improve obesity and Type 2 diabetes.